Replies to post #24631 on Cytodyn Inc (CYDY)

[trding]

Turns out the pipeline meds were all a total failure.

That’s the big difference. With Combo PE already known and the number of patients we know that are in the rollover study, I feel very confident the final results will be good, which we should know very soon...luckily before they need additional financing.

[Inoviorulez]

No No No this is nothing like RXII, you can't compare cytodyn with RXII. Cytodyn has already passed a phase 3 and is ready to file its BLA for FDA approval of HIV product in Q4 2018 (before the end of the year) RXII didn't even obtain decent results in phase 2. It is nowhere close to phase 3 and has started over with immuno-oncology in phase 1.

This is a different story because Cytodyn has Pro-140 which has already passed a phase 3 combo study and is near FDA approval. Does anyone bother to research stocks anymore or do any DD at all? Apparently not.